Intensive Glucose Lowering and Cardiovascular Disease Prevention in Diabetes: Reconciling the Recent Clinical Trial Data

Circulation - United States
doi 10.1161/circulationaha.109.913350
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Effects of Intensive Glucose Lowering in Type 2 Diabetes

Yearbook of Endocrinology
2009English

Recent Data on Mediterranean Diet, Cardiovascular Disease, Cancer, Diabetes and Life Expectancy

Bratislava Medical Journal
2015English

The Diabetes Prevention Program. Design and Methods for a Clinical Trial in the Prevention of Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
1999English

Diabetes, Bone and Glucose-Lowering Agents: Basic Biology

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-Of-The-Art Review

Mayo Clinic Proceedings
Medicine
2018English

Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes Mellitus

Nature Reviews Endocrinology
EndocrinologyMetabolismDiabetes
2010English

Update in Diabetes and Cardiovascular Disease: Synthesizing the Evidence From Recent Trials of Glycemic Control to Prevent Cardiovascular Disease

Current Opinion in Lipidology
NutritionGeneticsCell BiologyMolecular BiologyCardiologyEndocrinologyCardiovascular MedicineDieteticsMetabolismDiabetes
2010English

Blood Pressure Lowering for Cardiovascular Disease

The Lancet
Medicine
2016English

Systematic Review of Lipid Lowering for Primary Prevention of Coronary Heart Disease in Diabetes

BMJ
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy